These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Optimization of chemotherapy regimens in children with primary pulmonary tuberculosis]. Ovchinnikova IuE; Starshinova AA; Dovgaliuk IF Probl Tuberk Bolezn Legk; 2009; (1):36-40. PubMed ID: 19256011 [TBL] [Abstract][Full Text] [Related]
4. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)]. Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898 [TBL] [Abstract][Full Text] [Related]
5. Coccidioides immitis and Mycobacterium tuberculosis diagnosed by endoscopic ultrasound. Naidu VG; Tammineni AK; Biscopink RJ; Davis TL; Veerabagu MP J S C Med Assoc; 2009 Feb; 105(1):4-7. PubMed ID: 19331085 [TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of an intensive chemotherapy stage in new cases of pulmonary tuberculosis and diabetes mellitus]. Chernykh NA; Karachunskiĭ MA; Kaminskaia GO; Kossiĭ IuE Probl Tuberk Bolezn Legk; 2004; (12):30-2. PubMed ID: 15719663 [TBL] [Abstract][Full Text] [Related]
7. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis. Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119 [TBL] [Abstract][Full Text] [Related]
8. [Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results]. Belianin II; Shmelev EI Probl Tuberk Bolezn Legk; 2007; (2):31-8. PubMed ID: 17419333 [TBL] [Abstract][Full Text] [Related]
9. Anti-tuberculosis 4FDC tablets--mystery to chemistry. Dekker TG; Lötter AP Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831 [No Abstract] [Full Text] [Related]
10. Ultrashort-course chemotherapy for culture-negative pulmonary tuberculosis--a qualified success. Cowie RL; Langton ME; Escreet BC S Afr Med J; 1985 Dec; 68(12):879-80. PubMed ID: 4071345 [TBL] [Abstract][Full Text] [Related]
11. [Efficiency of an intensive stage of chemotherapy for tuberculosis in elderly and senile patients]. Karachunskiĭ MA; Uvarova TE Probl Tuberk Bolezn Legk; 2004; (3):19-21. PubMed ID: 15338894 [TBL] [Abstract][Full Text] [Related]
12. [Ascites by peritoneal tuberculosis]. de Escalante Yangüela B; Aibar Arregui M; Sáenz Abad D; Torrubia Pérez CB An Med Interna; 2007 May; 24(5):253-4. PubMed ID: 17929388 [No Abstract] [Full Text] [Related]
13. [Drug-resistant pulmonary tuberculosis at the penitentiaries]. Kononets AS Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326 [TBL] [Abstract][Full Text] [Related]
14. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Mitchison DA Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106 [TBL] [Abstract][Full Text] [Related]
15. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients]. Khodashova ML; Iuditskiĭ MV; Semenova OV Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896 [TBL] [Abstract][Full Text] [Related]
16. [Loculated ascitis by peritoneal tuberculosis]. de Escalante Yangüela B; Aibar Arregui M; Sáenz Abad D; Blanca Torrubia Pérez C An Med Interna; 2007 Apr; 24(4):205-6. PubMed ID: 17879484 [No Abstract] [Full Text] [Related]
17. [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis]. Semenova OV Probl Tuberk Bolezn Legk; 2003; (11):22-5. PubMed ID: 14689793 [TBL] [Abstract][Full Text] [Related]
18. [Improved technology of chemotherapy of pulmonary tuberculosis complicated by other diseases]. Gavril'ev SS; Nikolaev VP; Vinokurova MK; Petukhova NIu; Gavril'eva LP; Malogulova ISh Probl Tuberk; 2001; (2):8-11. PubMed ID: 11490482 [TBL] [Abstract][Full Text] [Related]